Predictor variable | HR (95% CI) | P | |
---|---|---|---|
MACCE | Age ≥ 65 years | 0.92 (0.58–1.465) | 0.729 |
Male | 0.663 (0.398–1.106) | 0.116 | |
HT | 0.954 (0.594–1.532) | 0.845 | |
DM | 0.822 (0.537–1.26) | 0.369 | |
HP | 0.89 (0.588–1.346) | 0.581 | |
OMI | 0.85 (0.508–1.422) | 0.536 | |
PAD | 1.317 (0.674–2.575) | 0.42 | |
Stroke | 1.028 (0.632–1.672) | 0.912 | |
eGFR < 90 | 0.999 (0.639–1.561) | 0.996 | |
LVEF < 0.5 | 2.121 (1.304–3.452) | 0.002 | |
CTO-R | 0.541 (0.353–0.83) | 0.005 | |
LM disease | 1.211 (0.734–2.001) | 0.454 | |
Cardiac death | Age ≥ 65 years | 0.501 (0.172–1.459) | 0.205 |
Male | 0.437 (0.148–1.288) | 0.133 | |
HT | 1.548 (0.501–4.778) | 0.447 | |
DM | 0.781 (0.295–2.065) | 0.618 | |
HP | 0.948 (0.365–2.461) | 0.913 | |
OMI | 0.548 (0.171–1.75) | 0.31 | |
PAD | 2.332 (0.739–7.364) | 0.149 | |
Stroke | 0.925 (0.31–2.758) | 0.889 | |
eGFR < 90 | 1.369 (0.485–3.861) | 0.553 | |
LVEF < 0.5 | 4.804 (1.895–12.177) | 0.001 | |
CTO-R | 0.239 (0.076–0.751) | 0.014 | |
LM disease | 3.884 (1.544–9.771) | 0.004 |